Women at risk of premature delivery were divided randomly into 2 groups of 80 each. Mefenamic acid 500mg 3 times a day or a placebo was given in a double blind fashion. Preterm delivery occurred in 15% of the treated group and 40% of the control group (p < 0.005). The mean birth weight in the test group was higher as compared to the controls. There were no cases of foetal malformations in either of the groups. The results support the use of Mefenamic acid in preventing premature labour.
Get full access to this article
View all access options for this article.
References
1.
Arcilla R.A., Thilenius O.G. and Rannigger K. (1969). Congestive heart failure from suspected ductal closure in utero. J Paediatr.75: 74-78
2.
Creasy R.K., Gummer B.A. and Liggins G.C. (1980). Systems for predicting spontaneous preterm birth . Obstet & Gynaecol55: 692-695
3.
Friedman WF, Hirschklau M.J. and Printz M.P. (1976). Pharmacologic closure of patent ductus arteriosus in the premature infant. N EngJ Med295: 526-529
4.
Heymann M.A., Rudolph A.M. and Silverman N.H. (1976). Closure of ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Eng J Med295: 530-533
5.
Isaacs P E T, Sladen G.E. and Filipe I. (1987). Mefenamic acid enteropathy. J Clin Pathol40: 1221-1227
6.
Kaltreider D.F. and Johnson J.W. (1976). Patients at high risk for low birth weight delivery . Am J Obst Gynaecol124: 251-256
7.
Kingswell R.S. S (1987). Uses of mefenamic acid. (Letter)J Clin Pathol40: 1261-1267
8.
Niebyl J.R. and Johnson J W C (1980). Inhibition of preterm labour . Clin Obst & GGynaecol23: 115-126
9.
Phillips M.S., Fehilly B., Stewart S. and Dronfield M.W. (1983). Enteritis and Colitis associated with mefenamic acid. Br Med J287:1626
